Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer
NCT01259505
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
BIOLOGICAL:
CDCA1，URLC10，KIF20A，DEPDC1 and MPHOSPH1
Sponsor
Tokyo Medical University
Collaborators
[object Object]
[object Object]